FDA drug inspections of US manufacturing facilities decreased to focus on foreign oversight

While the Food and Drug Administration (FDA) conducted more foreign than domestic drug manufacturing inspections for the first time in 2015, staffing vacancies from 2016 onward followed by COVID-19 led to a significant decrease in foreign inspections. Only 3 foreign inspections were conducted in 2020.